NOD1 and cancer: Evaluation of the ability of BFT-1 to bind to NOD1 using binding assays showed that the specific binding of HIS-BFT-1 was markedly higher in NOD1-overexpressing cancer cells than in empty vector (EM)-expressing cancer cells (Fig. 3H).